Editorial: obesity in chronic liver diseases - increased infections; authors' reply

V Sundaram^{1

2}, R Jalan³

Affiliations

¹ Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA, USA. vinay.sundaram@cshs.org.
² Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. vinay.sundaram@cshs.org.
³ Liver Failure Group, Institute for Liver and Digestive Health, UCL Medical School, London, UK.

Editorial

V Sundaram et al. Aliment Pharmacol Ther. 2016 Jan.

. 2016 Jan;43(2):312.

doi: 10.1111/apt.13483.

V Sundaram^{1

2}, R Jalan³

¹ Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA, USA. vinay.sundaram@cshs.org.
² Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA. vinay.sundaram@cshs.org.
³ Liver Failure Group, Institute for Liver and Digestive Health, UCL Medical School, London, UK.

No abstract available

Comment on

Obesity is independently associated with infection in hospitalised patients with end-stage liver disease.
Sundaram V, Kaung A, Rajaram A, Lu SC, Tran TT, Nissen NN, Klein AS, Jalan R, Charlton MR, Jeon CY. Sundaram V, et al. Aliment Pharmacol Ther. 2015 Dec;42(11-12):1271-80. doi: 10.1111/apt.13426. Epub 2015 Oct 13. Aliment Pharmacol Ther. 2015. PMID: 26510540
Editorial: obesity in chronic liver diseases - increased infections.
Singh S, Loomba R. Singh S, et al. Aliment Pharmacol Ther. 2016 Jan;43(2):311-2. doi: 10.1111/apt.13463. Aliment Pharmacol Ther. 2016. PMID: 26741982 No abstract available.